
Semble, a UK-based healthcare technology company, has raised £30 million in a Series C round led by Revaia, with participation from Partech, Mercia Ventures, and Octopus Ventures.
SUMMARY
- Semble, a UK-based healthcare technology company, has raised £30 million in a Series C round led by Revaia, with participation from Partech, Mercia Ventures, and Octopus Ventures.
The company provides a unified practice management and care coordination platform for outpatient healthcare providers.
Its software helps clinicians and healthcare organisations manage patient journeys, streamline clinical and administrative workflows, and coordinate care through a single system.
More than 10 million patients have been treated via clinicians using Semble, and over 1,700 healthcare organisations including Nuffield Health, Welbeck, and London Doctors Clinic use its platform.
RECOMMENDED FOR YOU
TravelPerk acquisition news – Barcelona-based TravelPerk Acquired AmTrav
Oliver Bennett
Jun 18, 2024
Test Of Things Raises €1.2M To Fix The Cybersecurity Problem Of Connected Devices
Kailee Rainse
Apr 1, 2026
[Funding alert] London-based Vortexa Secures $34M in Series C Round Funding
Oliver Bennett
Jan 9, 2024
Read Also - Standard Chartered Appoints Shebani Baweja As Group Chief Data Officer
The new funding will support expansion across the UK and France, strengthen adoption among large healthcare groups, and further develop Semble’s AI-powered care orchestration capabilities.
What healthcare organisations need is intelligent orchestration across the entire care journey. The practices and groups that win over the next decade will be the ones that deliver the best patient experience end-to-end. This investment allows us to rapidly scale that vision across the UK and Europe. Said Christoph Lippuner ,CEO and co-founder of Semble.






